Furlan, A. C.
1602  results:
Search for persons X
?
2

'Toxic erythema' and eosinophilia associated with tocilizum..:

Sernicola, A. ; Carnicelli, G. ; Di Fraia, M....
Journal of the European Academy of Dermatology and Venereology.  34 (2020)  8 - p. , 2020
 
?
3

PO-0951: Which is the best once-daily schedule for partial ..:

Vinante, L. ; Avanzo, M. ; Furlan, C....
Radiotherapy and Oncology.  152 (2020)  - p. S508-S509 , 2020
 
?
 
?
5

EP-1139 Prognostic impact of hematological profile in oroph..:

Fanetti, G. ; Rojas, D.P. ; Marvaso, G....
Radiotherapy and Oncology.  133 (2019)  - p. S632-S633 , 2019
 
?
 
?
 
?
 
?
 
?
10

Multiple sclerosis prevalence in Salta City, Argentina:

Mellinger, S. ; Dias, D. ; Flores, N....
Multiple Sclerosis and Related Disorders.  25 (2018)  - p. 212-215 , 2018
 
?
11

Prognostic Significance of Immune Microenvironmental Factor..:

Muraro, E. ; Vaccher, E. ; Furlan, C....
International Journal of Radiation Oncology*Biology*Physics.  102 (2018)  3 - p. e242 , 2018
 
?
 
?
13

Levels of supplementation of inorganic selenium and vitamin..:

Zancanela, V. ; Furlan, A. C. ; Pozza, P. C....
Journal of Animal Physiology and Animal Nutrition.  102 (2017)  2 - p. , 2017
 
?
14

EP-1088: Is time from symptom to treatment a prognostic fac..:

Furlan, C. ; Polesel, J. ; Gobitti, C....
Radiotherapy and Oncology.  119 (2016)  - p. S523-S524 , 2016
 
?
 
1-15